New Guidance on Cannabis Use for Treatment-Resistant Epilepsy

A new review draws from existing research, as well as clinical experience, to provide interim guidance on the use of cannabinoids for pediatric and adult refractory epilepsy.

Related Keywords

Australia ,United States ,United Kingdom ,Texas ,Australian ,American ,British ,Daniel Freedman ,University Of Texas At Austin ,Transportation Security Administration ,American Epilepsy Society ,American Academy Of Neurology ,Drug Enforcement Agency ,New South Wales ,British Journal ,American Academy ,Unapproved Cannabinoids ,Drug Enforcement ,Adverse Effects ,Epilepsy ,Seizure Disorder ,Seizure ,Cannabinoid ,Medical Marijuana ,Medical Cannabis ,Confusional States ,Cute Memory Disorders ,Medically Intractable Epilepsy ,Nausea ,Addiction ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Ketogenic Diet ,Psychosis ,Withdrawal Syndrome ,Clinical Research ,Clinical Trials ,Linical Studies ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,